A major breakthrough in cancer investigation is occurring with the use of nanobodies to re-engage dysfunctional p53. This essential malignant suppressor protein is frequently inactivated in several types of cancer, https://dmozbookmark.com/story21941024/nanobodies-reactivate-tumor-suppressor-p53-a-potential-pathway-for-cancer-therapy